Progenics Pharmaceuticals Competitors and Similar CompaniesClear all
Progenics Pharmaceuticals's competitors and similar companies include Halozyme Therapeutics and Pharmacyclics.
 Progenics Pharmaceuticals Progenics Pharmaceuticals is a biopharmaceutical company focused on developing innovative therapeutics for cancer patients. |  Halozyme Therapeutics Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment. |  Pharmacyclics Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. | |
Founding Date | Founding Date 1986 | Founding Date 1998 | Founding Date 1991 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations New York, US HQ Billerica, US | Locations San Diego, US HQ | Locations Sunnyvale, US HQ |
Employees | Employees 49 | Employees 373157% increase | Employees 6551% decrease |
Financial | |||
Revenue (est.) | Revenue (est.) $35m (FY, 2019) | Revenue (est.) $1.4b (FY, 2025) | Revenue (est.) $729.7m (FY, 2014) |
Cost of goods | Cost of goods $3.2m (FY, 2019) | Cost of goods $228.8m (FY, 2025) | Cost of goods $40.4m (FY, 2014) |
Gross profit | Gross profit $31.8m (FY, 2019) | Gross profit $1.2b (FY, 2025) | Gross profit $689.3m (FY, 2014) |
Net income | Net income ($68.6m) (FY, 2019) | Net income $316.9m (FY, 2025) | Net income $86.1m (FY, 2014) |
For sources of this data, please see the company profile
View Company Profiles
Halozyme Therapeutics
HQ
San Diego, US
Employees
373
Halozyme Therapeutics is a biotechnology company focused on developing and commercializing cancer therapies that target the tumor microenvironment.
View companyPharmacyclics
HQ
Sunnyvale, US
Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases.
View company